RadNet, Inc. is a provider of diagnostic imaging services in the United States, operating imaging centers directly or through joint ventures with hospitals and health systems. The company offers multi-modality services including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology, and fluoroscopy. Its Digital Health segment develops and deploys artificial intelligence suites and computerized systems for the distribution, display, storage, and retrieval of digital images, as well as radiology information systems. Internationally, the company provides teleradiology services for the United Kingdom's National Health Service through its majority-owned subsidiary, The HLH Imaging Group Limited. RadNet serves referring physicians, radiology groups, and third-party payors across regional markets in Arizona, California, Delaware, Florida, Maryland, Virginia, New Jersey, Texas, and New York. The company was founded in 1981 and has grown through organic expansion and acquisitions, including Tower Imaging, Diagnostic Imaging Systems, Radiologix, Aidence Holding B.V., and Quantib B.V.

Summarised from the company's own disclosures, fiscal year ended Mar 2026

Industry Medical Care Facilities Homepage radnet.com
Sector Healthcare IR page radnet.com/investor-day
Tags
diagnostic imaging, outpatient radiology, teleradiology, medical imaging software, radiology ai, multi-modality imaging, mammography, nuclear medicine, healthcare it, The HLH Imaging Group Limited, Heart & Lung Imaging Limited, DeepHealth Inc., Aidence Holding B.V., Quantib B.V., eRad Inc., DeepHealth OS, WIN-NextGen, Tower Imaging, Diagnostic Imaging Systems, Radiologix, Primedex Health Systems Inc.
Press page radnet.com/about-radnet/news

Metrics

Valuation  
Market cap $ 6.184B
Market cap (USD) $ 6.184B
P/E -276.32
PEG —
P/BV 5.52
P/S 2.59
P/OCF 17.78
P/FCF 72.27
Dividend yield —
Turnover / mcap —
Returns  
ROE -1.9%
ROI -0.86%
ROIC 1.5%
Profit margin -0.91%
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable No
Margin expanding No
Buying back stock No
Diluting (TTM) Yes
Debt/Equity 118.2%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 53
Quality score -29.4%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000
Revenue 2.04B 1.83B 1.617B 1.43B 1.315B 1.072B 1.028B 975.146M 922.186M 884.535M 809.628M 717.569M 702.986M 85.036M 619.8M 551.815M 524.368M 498.815M 137.277M 140.259M 139.281M 111.837M 87.965M
Net profit -18.652M 2.793M 3.044M 10.65M 24.727M -14.84M 14.756M 32.243M 53K 7.23M 7.709M 1.376M 2.12M 64.517M 7.231M -12.852M -2.267M -12.836M -14.576M -2.267M -5.551M 14.501M 2.614M
Free cash flow 85.569M 44.953M 44.263M 26.966M 6.487M — 30.169M 44.574M 80.889M 32.39M 24.073M 19.264M 17.799M 30.821M 14.916M 26.591M 45.866M 16.233M 13.28M 17.202M 5.881M 6.117M 3.548M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000
Share price 71.35 69.84 34.77 18.83 30.11 19.57 20.3 10.17 10.1 6.45 6.18 8.54 1.67 2.46 2.45 2.45 2.02 7.64 — — — — —
Price performance 12m 0.02 1.01 0.85 -0.37 0.54 -0.04 1 0.01 0.57 0.04 -0.28 4.11 -0.32 0 0 0.21 -0.74 -0.18 — — — — —

Filed figures

Figure Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (USD) 164M 156M 149M 155M 130M 135M 166M 164M 186M 200M
↳ YoY growth +0.8% -5.3% -4.2% +3.9% -16.3% +4.2% +23.2% -1.6% +13.5% +7.8%
↳ 5y CAGR +5.0% +3.8% +2.2% +0.9% -4.5% -3.8% +1.4% +1.9% +3.7% +9.1%
Borrowings, current (USD) 26.6M 592,000 — — 39.8M 11.2M 12.4M 18M 24.7M 25.4M
Borrowings, non-current (USD) 648M 621M 675M 706M 662M 743M 839M 812M 992M 1.06B
Lease liabilities (USD) — — — 489M 532M 643M 662M 661M 713M 769M
Cash and deposits (USD) 20.6M 51.3M 10.4M 40.2M 102M 135M 128M 343M 740M 767M
Intangible assets (USD) 42.7M 40.4M 40.6M 43M 52.4M 56.6M 106M 90.6M 81.4M 149M
Right-of-use assets (USD) — — — 445M 484M 584M 604M 596M 640M 690M
Net debt (borrowings + leases - cash) (USD) 654M 570M 665M 1.15B 1.09B 1.26B 1.39B 1.15B 989M 1.09B
Cash flow detail
Operating cash flow (USD) 91.6M 142M 117M 104M 234M 149M 146M 221M 233M 299M
Purchases of property, plant and equipment (USD) -59.3M -61.3M -72.2M -74.2M — — — — — —
Purchases of intangible assets (USD) — — — 0.00 0.00 -5.13M 0.00 0.00 — —
Change in receivables (cash effect) (USD) -47.1M -37.2M 2.15M -17.5M 25.2M -5.89M -30.1M 2.65M -21.8M -9.56M
Change in payables (cash effect) (USD) 4.93M 36.2M 28M 17.3M 45.1M 9.92M 49.8M 15.1M 37.1M 52.4M
Interest paid (cash effect) (USD) -37.5M -34.2M -37M -46.3M -39.5M -29M -39.2M -64.7M -84.6M -72.3M
Income taxes paid (cash effect) (USD) -2.8M -4.94M -4.93M -5.88M -5.07M -1.95M -587,000 -1.59M -4.17M -4.56M
Share-based compensation (USD) 5.83M 6.79M 7.66M 8.73M 12.4M 25.2M 23.8M 26.8M 29.8M 54.6M
Operating cash flow before change in receivables (USD) 139M 179M 115M 122M 209M 155M 176M 218M 255M 308M
Free cash flow (OCF - PPE - intangibles) (USD) 32.4M 80.9M 44.6M 30.2M — — — — — —
Income detail
Total comprehensive income (USD) 7.69M 1.22M 40.9M 13.2M -17.8M 47.9M 33.4M 38.5M 42.3M 32.4M
Comprehensive income to owners (USD) 8.46M -801,000 35.1M 4.47M -30.9M 28.4M 10.4M 11.2M 6.22M -4.71M
Provision for credit losses (USD) 45.4M 46.6M 0.00 0.00 — — — — — —
Credit cost ratio (credit losses / average receivables) (%) 27.8% 29.1% 0.0% 0.0% — — — — — —
Reported Mar 19, 2018 Mar 19, 2018 Mar 16, 2020 Mar 1, 2022 Mar 1, 2022 Mar 1, 2022 Mar 1, 2023 Feb 29, 2024 Mar 3, 2025 Mar 2, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

· Total Company Revenue increased 22.1% to $638.3 million in the third quarter of 2026 from $522.9 million in the third quarter of 2025; Revenue from the Digital Health reportable segment (inclusive of intersegment revenue) increased 32.6% to $32.9 million in the third quarter of 2026 from $24.8 million in the third quarter of 2025

· Total Company Adjusted EBITDA(1) was $105.0 million in the third quarter of 2026 as compared with $84.9 million in the third quarter of 2025, an increase of 23.8%; Digital Health reportable segment Adjusted EBITDA(1) decreased 11.8% to $3.0 million in the third quarter of 2026 from $3.5 million in the third quarter of 2025

· Total Company Adjusted EBITDA(1) margin increased to 16.5% in the third quarter of 2026 as compared with 16.2% in the third quarter of 2025

· Adjusting for unusual or one-time items in the quarter, Adjusted Diluted Earnings Per Share(3) was $0.30 for the third quarter of 2026; This compares with Adjusted Diluted Earnings Per Share(3) of $0.24 for the third quarter of 2025

· In the third quarter of 2026, aggregate advanced imaging (MRI, CT and PET/CT) procedural volumes increased 19.9% and same-center advanced imaging procedural

Tweet

email-button-icon

LOS ANGELES, Oct. 29, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers and digital health solutions, announced today that it will host a conference call to discuss its third quarter 2026 financial results on Monday, November 9, 2026 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).

Investors are invited to listen to RadNet’s conference call by dialing 844-744-1280. International callers can dial 412-564-6465. There will also be simultaneous and archived webcasts available at https://viavid.webcasts.com/starthere.jsp?ei=1780998&tp_key=f33fc0e8e8 . An archived replay of the call will also be available and can be accessed by dialing 844-512-2921 from the U.S., or 412-317-6671 for international callers, and using the passcode 10213035.

About RadNet, Inc.
RadNet, Inc. is a leading national provider of freestanding, fixed-site diagnostic imaging services in the United States based on the number of locations and annual imaging revenue. RadNet has a network of owned and/or operated outpatient imaging centers. RadNet’s imaging center markets include Arizona, California, Delaware, Florida, Idaho, Indiana, Maryland, New Jersey, New York, Texas and Virginia. In addition, RadNet provides radiology information technology and artificial intelligence solutions marketed under the DeepHealth brand, teleradiology professional services and other related products and services to customers in the diagnostic imaging industry globally. Together with contracted radiologists, and inclusive of full-time and per diem employees and technologists, RadNet has over 12,000 team members. Learn more at www.radnet.com . 

CONTACT:

RadNet, Inc.
Mark Stolper
Executive Vice President and Chief Financial Officer
310-445-2800

29 October, 2026

RadNet - Advancing Imaging Through Innovation & Technology

Career Opportunities

Career Opportunities

TIME World's Most Impactful Companies 2026

West Coast Operations
1510 Cotner Avenue
Los Angeles, CA 90025
Phone: 310-445-2800

East Coast Operations
BECO Towers
10461 Mill Run Circle, Suite 1100
Owings Mills, MD 21117
Phone: 443-436-1100

**DeepHealth (Digital Health Division) **
212 Elm St.
Somerville, MA 01244

Privacy Settings Privacy Statement Your Privacy Choices Disclaimer HIPAA Notification Anti-Discrimination Policy Accessibility Statement Recruitment Privacy Notice Applicant Rights and Disclosures

© 2026 RadNet Inc. All rights reserved. Unauthorized use is strictly prohibited.

We use cookies to give you the best experience on our website. Please review our Privacy policy to learn more. Manage your cookie preferences.

Accept All

Essential Information

This collected information is necessary to provide you with the critical features available on our Website. Because this information is essential to your experience, you are unable to alter these settings and still use the Website.

Non-Essential Information

This information is used to enhance your experience on our Website. If we are unable to collect this important yet non-essential information, certain functions and items (e.g. chat and location maps) will not be available or work as intended.

Reject Non-Essential

CCPA Consumer Rights Request Form

The California Consumer Privacy Act of 2018 (CCPA) grants California residents specific rights to control your personal information. To exercise these rights, you can complete and submit the form linked below. Please note that we may require additional information or documentation to verify your identity before processing your request. For more information about how we collect, use, handle, and protect your personal information, please refer to our Privacy policy .

CCPA Consumer Rights Request Form

Tweet

email-button-icon

RadNet Announces Agreement to Acquire ONRAD

ONRAD Acquisition Presentation

Shareholder Presentation • PDF

View Presentation (PDF)

  • Adds a radiology professional services platform offering teleradiology and in-hospital staffing for hospitals and health systems
     
  • Enables RadNet to seamlessly combine radiology professional services, AI-powered technology solutions and outpatient imaging operations into an integrated offering, transforming radiology workflows and ultimately improving patient care
  • Uniquely positions RadNet with an expanded offering to address the full range of care settings where imaging is performed inside and outside of hospitals
  • Acquisition adds to RadNet a capital-light, high-margin management services platform supporting more than 225 hospital facilities across 26 states with more than 130 contracted radiologists
  • ONRAD is expected to add $190 million to $200 million of Revenue and $60 million to $65 million of Adjusted EBITDA(1) to RadNet in its first year of operation after closing
  • RadNet and ONRAD management will host a conference call and webcast to discuss the transaction in more detail on Tuesday, October 27 
     

LOS ANGELES, Oct. 26, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT) (“RadNet” or the “Company”), a national leader in providing high-quality, cost-effective outpatient diagnostic imaging services and a global developer of digital health solutions, today announced that it has entered into a definitive agreement to acquire ONRAD, Inc. (ONRAD).  ONRAD, through its more than 130 contracted radiologists, is a provider of teleradiology and in-hospital professional radiology staffing services for hospitals, health systems and other diagnostic imaging sites of care.  The transaction is expected to close in early 2027 and is subject to customary regulatory review and closing conditions.  Upon closing, ONRAD shareholders will receive a cash payment of $350 million and 5 million shares of RadNet, Inc. common stock, subject to customary adjustments.  In addition, an earnout of up to $210 million in value will be payable upon achievement of target EBITDA for 2027.  The earnout is payable in cash, RadNet common stock, or a combination thereof, at RadNet’s election.

“This is the next step in building an imaging company with comprehensive solutions that brings technology, radiology professional services and imaging operations together to address some of healthcare’s most pressing challenges and needs,” said Dr. Howard Berger, President and CEO of RadNet.  “Connecting RadNet’s established AI-enabled digital health technology and imaging center operational expertise with ONRAD’s teleradiology and professional staffing solutions unites the capabilities needed to address the entire continuum of diagnostic imaging under one company.  The acquisition will enhance RadNet’s portfolio of solutions for hospitals and health systems, outpatient freestanding centers, urgent care facilities, freestanding emergency departments and physician offices.”

Dr. Berger continued, “I welcome ONRAD’s executive team, its contracted radiologists and all other ONRAD team members into the RadNet family.  This transaction is a significant additional step in leading our industry forward and demonstrating the impact that a transformation to workflow solutions in diagnostic imaging can have in advancing early detection, population health and improved patient outcomes.”

Through its contracted radiologists, ONRAD provides remote teleradiology final-read interpretations across many healthcare settings and in-hospital professional radiology staffing services, including interventional radiology, for hospitals and health systems_._  Upon closing, ONRAD will become the foundation for RadNet's third reportable operating segment, Radiology Professional Services.  With the addition of this third operating segment, RadNet becomes a comprehensive radiology services and solutions provider, addressing the imaging continuum across the full range of care settings, including hospitals, freestanding ambulatory outpatient centers, primary and specialty care physician offices and standalone urgent care and emergency department facilities.

Strategic Rationale

  • Connects three complementary businesses to provide comprehensive imaging solutions.  Combining RadNet outpatient imaging operations and DeepHealth AI-enabled digital health solutions with the ONRAD radiology professional services platform will bring together comprehensive expertise in the diagnostic imaging industry within one company.  Integrating these capabilities for customers and partners across all diagnostic imaging settings is expected to create efficiencies, improve patient care and lower costs in an unequaled approach.
  • Expands RadNet into hospital-based radiology.  Hospitals and health systems account for more than 50% of U.S. diagnostic imaging volume.(2)  ONRAD will provide RadNet with an established platform to support in-hospital and remote professional radiology interpretation services while also expanding the RadNet offerings to its existing joint venture partners.
  • Addresses growing market demand.  U.S. imaging demand growth is outpacing the supply of trained radiologists.  With ONRAD, RadNet will be positioned to further help address this gap by integrating AI-enabled technology with teleradiology and professional staffing services, creating opportunities to transform workflows, support case prioritization and better match interpretation capacity to demand.
  • Adds a fast-growing, high-margin capital-light business.  ONRAD has demonstrated consistent annual revenue growth between 10% and 20% over the last several years with Adjusted EBITDA(1) margins exceeding 30%.  RadNet believes ONRAD will require very little capital to maintain and grow organically.
     

“For 20 years, ONRAD has built long-standing relationships with hospitals and health systems delivering reliable, high-quality radiology coverage,” said Dave Engert, President and CEO of ONRAD.  “Joining RadNet not only gives us the scale, resources and technology to meet the growing needs of our current and prospective customers, but it also enables us to offer a unique imaging model that addresses the full continuum of care from outpatient imaging centers to the acute care environment.  The potential to further meet the ever-increasing demand for imaging services along with improving patient outcomes is what excites me most about our future together.”

Conference Call and Webcast
RadNet will host a conference call and webcast at 8:00 a.m. Eastern Time on Tuesday, October 27, 2026 to discuss the transaction in further detail.  To join by phone, dial 1-844-744-1280 for the U.S. and Canada and 1-412-564-6465 for international callers. A live webcast will be available at https://viavid.webcasts.com/starthere.jsp?ei=1780997&tp_key=417a069370.

Robert W. Baird & Co. is serving as exclusive financial advisor to ONRAD, which is a portfolio company of Housatonic Partners. 

About RadNet, Inc.
RadNet, Inc. is a leading national provider of freestanding, fixed-site diagnostic imaging services in the United States based on the number of locations and annual imaging revenue.  RadNet has a network of owned and/or operated outpatient imaging centers.  RadNet’s imaging center markets include Arizona, California, Delaware, Florida, Idaho, Indiana, Maryland, New Jersey, New York, Texas and Virginia.  In addition, RadNet provides radiology information technology and artificial intelligence solutions marketed under the DeepHealth brand, teleradiology professional services and other related products and services to customers in the diagnostic imaging industry globally.  Together with contracted radiologists, and inclusive of full-time and per diem employees and technologists, RadNet has over 12,000 team members.  Learn more at radnet.com .   

About ONRAD, Inc. 
ONRAD, Inc. is a leading radiology services company, delivering remote teleradiology final-read impressions and full-service radiology solutions for hospitals, radiology practices, outpatient clinics and imaging centers. Its spectrum of services includes reading remote and onsite diagnostic studies, interventional radiology, medical directorship, analytics, peer review, billing and quality oversight — all on the industry's most advanced, integrated, AI-powered technology platform. ONRAD reads all modalities and has been Joint Commission accredited since its inception.  

Forward-Looking Statements 
This press release includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact, included in this press release that address activities, events or developments that RadNet expects, believes or anticipates will or may occur in the future are forward-looking statements. Terminology such as “could,” “believe,” “anticipate,” “intend,” “estimate,” “expect,” “may,” “continue,” “predict,” “potential,” “project” and similar expressions are intended to identify forward-looking statements. These statements include, but are not limited to, statements regarding the transaction discussed herein, the expected timing and completion of such transaction, the anticipated benefits of such transaction, the potential earnout amount, the expected financial impact of the transaction on RadNet and other statements that are not historical facts. Forward-looking statements are based on current plans, estimates, expectations and assumptions as of the time they are made, are not guarantees of future performance and should not be relied on as predictions of future events, and there can be no assurance that such estimates, assumptions and expectations will prove to have been correct. These forward-looking statements involve risks and uncertainties, many of which are difficult to predict and are generally outside RadNet’s control, and other factors that could cause RadNet’s actual results or financial condition to differ materially from those expressed or implied by forward-looking statements, including (i) the risk that the conditions to the closing of the transaction, including required regulatory approvals, are not satisfied or waived on a timely basis or at all, and the risk that the transaction may not be completed on the anticipated terms, in the anticipated timeframe or at all, (ii) the occurrence of any event that could give rise to the termination of the definitive agreement for the transaction, (iii) the risks and costs associated with the transaction and integrating ONRAD and achieving the anticipated benefits of the transaction, (iv) potential disruption to the businesses of RadNet and ONRAD, including the ability to retain and hire key personnel and to maintain relationships with customers, suppliers and other business partners, as well as diversion of management’s time and attention from ordinary course business operations to completion of the transaction and integration matters, (v) potential litigation or regulatory action relating to the transaction, (vi) the effect of the transaction on RadNet’s indebtedness and leverage, credit ratings and liquidity, (vii) legislative, regulatory and economic developments, including in the healthcare industry, (viii) the effect of the announcement, pendency or completion of the transaction on the market price of RadNet’s common stock, and (ix) the other risks described under “Risk Factors” in RadNet’s most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q. There may be additional risks, uncertainties and factors that we do not currently view as material or that are not necessarily known. Please read the Company’s filings with the SEC, which are available on the SEC’s website at https://www.sec.gov , for a discussion of risks and uncertainties that could cause actual results to differ from those in such forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. All forward-looking statements in this press release are qualified in their entirety by these cautionary statements. Except as required by law, RadNet undertakes no obligation and does not intend to update or revise any forward-looking statements, whether as a result of new information, future results or otherwise. 

No Offer or Solicitation 
This press release is for informational purposes only and shall not constitute or form part of, an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities, in any jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. 

References 
(1)The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, each from continuing operations and adjusted for losses or gains on the sale of equipment, other income or loss, debt extinguishments and non-cash equity compensation.  Adjusted EBITDA includes equity earnings in unconsolidated operations and subtracts allocations of earnings to non-controlling interests in subsidiaries, and is adjusted for non-cash or extraordinary and one-time events taken place during the period.  
   
Adjusted EBITDA is a non-GAAP financial measure used as analytical indicator by RadNet management and the healthcare industry to assess business performance, and is a measure of leverage capacity and ability to service debt.  Adjusted EBITDA should not be considered a measure of financial performance under GAAP, and the items excluded from Adjusted EBITDA should not be considered in isolation or as alternatives to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the consolidated financial statements as an indicator of financial performance or liquidity. As Adjusted EBITDA is not a measurement determined in accordance with GAAP and is therefore susceptible to varying methods of calculation, this metric, as presented, may not be comparable to other similarly titled measures of other companies.  

The Company’s guidance or target for ONRAD’s addition to Adjusted EBITDA is also a non-GAAP financial measure that excludes or otherwise has been adjusted for non-GAAP adjustment items from the Company’s GAAP financial statements. When the Company provides guidance or its target for ONRAD’s addition to Adjusted EBITDA, it does not provide a reconciliation of the GAAP measure as it is unable to predict with a reasonable degree of certainty the actual impact of the non-GAAP adjustment items. By their very nature, non-GAAP adjustment items are difficult to anticipate with precision because they are generally associated with unexpected and unplanned events that impact the Company and its financial results. Therefore, the Company is unable to provide a reconciliation of these measures without unreasonable efforts.  

(2)Based on a Signify analysis. 

  
RadNet Media Contacts  
Jane Mazur  
Senior Vice President, Corporate Communications  
+1 585-355-5978  
[email protected]     
 
Mark Stolper 
Executive Vice President and Chief Financial Officer 
+1 310-445-2800

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/05e518ec-4d83-4fcc-a69f-3e80e67f4d30

 

26 October, 2026

RadNet - Advancing Imaging Through Innovation & Technology

Career Opportunities

Career Opportunities

TIME World's Most Impactful Companies 2026

West Coast Operations
1510 Cotner Avenue
Los Angeles, CA 90025
Phone: 310-445-2800

East Coast Operations
BECO Towers
10461 Mill Run Circle, Suite 1100
Owings Mills, MD 21117
Phone: 443-436-1100

**DeepHealth (Digital Health Division) **
212 Elm St.
Somerville, MA 01244

Privacy Settings Privacy Statement Your Privacy Choices Disclaimer HIPAA Notification Anti-Discrimination Policy Accessibility Statement Recruitment Privacy Notice Applicant Rights and Disclosures

© 2026 RadNet Inc. All rights reserved. Unauthorized use is strictly prohibited.

We use cookies to give you the best experience on our website. Please review our Privacy policy to learn more. Manage your cookie preferences.

Accept All

Essential Information

This collected information is necessary to provide you with the critical features available on our Website. Because this information is essential to your experience, you are unable to alter these settings and still use the Website.

Non-Essential Information

This information is used to enhance your experience on our Website. If we are unable to collect this important yet non-essential information, certain functions and items (e.g. chat and location maps) will not be available or work as intended.

Reject Non-Essential

CCPA Consumer Rights Request Form

The California Consumer Privacy Act of 2018 (CCPA) grants California residents specific rights to control your personal information. To exercise these rights, you can complete and submit the form linked below. Please note that we may require additional information or documentation to verify your identity before processing your request. For more information about how we collect, use, handle, and protect your personal information, please refer to our Privacy policy .

CCPA Consumer Rights Request Form

Prompts

RadNet, Inc. (ticker RDNT), listed in United States.

Company History

Date Change Detail
Nov 28, 2006 Renamed PRIMEDEX HEALTH SYSTEMS INC → RADNET, INC.

ETFs Holding RadNet, Inc.

ETF Weight in ETF Shares Market value As of
RSMC 3.53% 336,201 $ 25.85M Nov 17, 2026
SMCO 2.22% 42,095 $ 3.237M Nov 17, 2026
FFOX 1.31% 51,166 $ 3.155M Jun 30, 2026
LFSC 0.92% 15,398 $ 1.167M Aug 31, 2026
MEDI 0.90% 4,944 $ 375.942K Nov 12, 2026
LITL 0.55% 419 $ 31.391K Nov 17, 2026
MSSM 0.32% 29,916 $ 2.268M Aug 31, 2026
JMEE 0.28% 106,384 $ 7.97M Nov 17, 2026
AVSC 0.24% 100,742 $ 7.746M Nov 16, 2026
RUSC 0.17% 2,227 $ 137.339K Jun 30, 2026
TMSL 0.14% 60,087 $ 3.706M Jun 30, 2026
DFAS 0.13% 569,859 $ 43.332M Nov 12, 2026
FFF 0.10% 88 $ 6,066.72 Sep 30, 2026
JSTC 0.07% 2,765 $ 212.601K Nov 17, 2026
CLSE short -0.07% -8,234 $ -624.302K Aug 31, 2026
RILA 0.06% 403 $ 25.703K Jul 31, 2026
SMDX 0.05% 831 $ 63.896K Nov 17, 2026
NBCR 0.04% 4,805 $ 364.315K Aug 31, 2026
DFAC 0.02% 243,367 $ 18.506M Nov 12, 2026
DCOR 0.01% 79,303 $ 6.03M Nov 12, 2026
DFSU 0.01% 3,642 $ 276.938K Nov 12, 2026
DFAU 0.01% 15,832 $ 1.204M Nov 12, 2026
DFUS 0.01% 20,135 $ 1.531M Nov 12, 2026
EBI 0.00% 151 $ 11.449K Aug 31, 2026
DFUV 0.00% 1,353 $ 102.882K Nov 12, 2026